<SEC-DOCUMENT>0001140361-14-034518.txt : 20140902
<SEC-HEADER>0001140361-14-034518.hdr.sgml : 20140901
<ACCEPTANCE-DATETIME>20140902102720
ACCESSION NUMBER:		0001140361-14-034518
CONFORMED SUBMISSION TYPE:	3/A
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20140725
FILED AS OF DATE:		20140902
DATE AS OF CHANGE:		20140902

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NATURES SUNSHINE PRODUCTS INC
		CENTRAL INDEX KEY:			0000275053
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				870327982
		STATE OF INCORPORATION:			UT
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		2500 WEST EXECUTIVE PARKWAY
		STREET 2:		SUITE 100
		CITY:			LEHI
		STATE:			UT
		ZIP:			84043
		BUSINESS PHONE:		(801) 341-7900

	MAIL ADDRESS:	
		STREET 1:		2500 WEST EXECUTIVE PARKWAY
		STREET 2:		SUITE 100
		CITY:			LEHI
		STATE:			UT
		ZIP:			84043

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMTEC INDUSTRIES INC
		DATE OF NAME CHANGE:	19821108

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
		CENTRAL INDEX KEY:			0001615258
		STATE OF INCORPORATION:			F4
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		3/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34483
		FILM NUMBER:		141076680

	BUSINESS ADDRESS:	
		STREET 1:		9TH FLOOR, NO.2 EAST FUXING ROAD
		CITY:			SHANGHAI
		STATE:			F4
		ZIP:			200010
		BUSINESS PHONE:		86 21 23138051

	MAIL ADDRESS:	
		STREET 1:		9TH FLOOR, NO.2 EAST FUXING ROAD
		CITY:			SHANGHAI
		STATE:			F4
		ZIP:			200010
</SEC-HEADER>
<DOCUMENT>
<TYPE>3/A
<SEQUENCE>1
<FILENAME>doc1.xml
<DESCRIPTION>FORM 3/A
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3/A</documentType>

    <periodOfReport>2014-07-25</periodOfReport>

    <dateOfOriginalSubmission>2014-08-04</dateOfOriginalSubmission>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0000275053</issuerCik>
        <issuerName>NATURES SUNSHINE PRODUCTS INC</issuerName>
        <issuerTradingSymbol>NATR</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001615258</rptOwnerCik>
            <rptOwnerName>Shanghai Fosun Pharmaceutical (Group) Co., Ltd.</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>NO.2 EAST FUXING ROAD</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>SHANGHAI</rptOwnerCity>
            <rptOwnerState>F4</rptOwnerState>
            <rptOwnerZipCode>200010</rptOwnerZipCode>
            <rptOwnerStateDescription>CHINA</rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle></officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>2854607</value>
                    <footnoteId id="F1"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <derivativeTable></derivativeTable>

    <footnotes>
        <footnote id="F1">Pursuant to adjustments under the Stock Purchase Agreement, the number of shares beneficially owned by the Reporting Person has been updated to reflect the actual number of shares purchased by the Reporting Person at closing.</footnote>
    </footnotes>

    <remarks></remarks>

    <ownerSignature>
        <signatureName>Shanghai Fosun Pharmaceutical (Group) Co., Ltd.  By: /s/ Qiyu Chen, Chairman</signatureName>
        <signatureDate>2014-09-02</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
